Panacea Biotec shares in focus as co gets UNICEF supply order worth Rs 127 crore

Panacea Biotec's shares are in focus as the company receives a Letter of Award from UNICEF for supplying 115 million doses of its bivalent oral polio vaccine (bOPV) worth approximately US$ 14.95 million (Rs 127 crore) in CY2025. The company recently posted a profit of Rs 4.8 crore, marking a strong recovery after three quarters of losses.